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ABSTRACT 
Objective: Evaluation of the self-emulsifying behaviour of type III lipid systems comprising mixed medium chain glycerides (Miglyol 812-Imwitor 
988) and wide range of hydrophilic surfactants in an attempt to identify self-emulsifying microemulsion formulations, prevaricate the 
crystallization tendency of Cremophor RH40 in the pre-microemulsion concentrate, to shed some light on the mechanistic behavior of these systems 
after aqueous dispersion.  
Methods: Non-ionic surfactants with HLB in the range 14 to 16.5 are investigated amongst these are; Cremophor RH40, Cremophor EL, Crillet 4 
(polysorbate 80), Crillet 1 (polysorbate 20) and Tagat O2. Optimum oil blends of Miglyol 812-Imwitor 988 and various non-ionic surfactant systems 
were verified using self-emulsification performance studies, oil droplet diameter measurements and dynamic equilibrium phase studies.  
Results: Oil blends of Miglyol 812 as an oil and Imwitor 988 as a cosurfactant were optimized for microemulsion systems at ratios of 1:1 in the case 
of Cremophor RH40 or EL, and at 2:3 in the case of Crillet 4 or Tagat O2. In order to obtain small droplet size and fast dispersion rate for type III 
lipid systems, hydrophilic surfactants with HLB values between 13 and 15 were found to be the optimum. 
Conclusion: Spontaneous micro-emulsification in type III lipid system was attributed to the “diffusion and stranding” theory. Yet, the formation of 
liquid crystalline phases as intermediate phases during dilution of the oil formulation with water appears to be quintessential for the mechanistics 
of emulsification regardless type of lipid class system. 
Keywords: SEDDS, SMEDDS, Lipid formulations, Medium chain mono-and glycerides, Poorly water-soluble compounds 




Self-emulsifying drug delivery systems (SEDDS) or self-micro-
emulsifying drug delivery system (SMEDDS) are isotropic mixtures 
of oils, non-ionic surfactants and co-surfactants which are used for 
improving lipophilic drug dissolution and absorption. These systems 
upon mild agitation in aqueous media form fine oil-in-water 
emulsions of droplet size of<5 µm in the case of SEDDS [1] or 
droplets with diameters between 5 and 140 nm in the case of 
SMEDDS [2]. It is proposed that enhancement in the water 
solubilisation region (L2) and the formation of interfacial liquid 
crystal on dilution with water are important to the mechanistic 
processes [3-4]. Furthermore, it is important in order to maximize 
the rate of absorption and thus bioavailability of oily formulations; 
one must maintain the drug in solution and avoid crystallization of 
the drug on dilution in the lumen of the gut [3, 5, 6]. Self-emulsifying 
technology for oral delivery use has recently witnessed the 
introduction of many self-emulsifying microemulsion formulations 
[7] including; Neoral®, originally marketed as ‘Sandimmune™’ 
(Cyclosporin A, calcineurin inhibitor; new drug application year NDA 
1999), Norvir® (Ritonavir, protease inhibitor; NDA 1996), 
Targretin® (Bexarotene, protease inhibitor; NDA 1999), Rapamune® 
(Sirolimus, mTOR kinase inhibitor: NDA 1999), Avodart® 
(Dutasteride, 5 alpha-reductase inhibitor; NDA 2001, Aptivus® 
(Tipranavir, protease inhibitor; NDA 2005), Amitiza® (Lubiprostone, 
chloride channel activator; NDA 2006), Xtandi® (Enzalutamide, 
androgen receptor inhibitor; NDA 2012) and Rayaldee® (Calcifediol, 
vitamin D analog; NDA 2016). However, the design for effective self-
micro-emulsifying drug delivery systems (SMEDDS) needs through 
an understanding of the various key elements which influence 
emulsification and how these factors interplay to affect absorption 
[3-4]. Pouton [8-9] has suggested a classification system for lipidic 
formulations based on their dispersions characteristics, digestibility 
and the physicochemical characteristics of the formulation 
components; principally the HLB of the surfactants and % glycerides 
content. Under this system, simple surfactant-free lipid solution 
formulations are classified as type I. Type II formulations are often 
referred to as SEDDS which comprise water-insoluble components; 
blends of glycerides and non-ionic surfactants with HLBs less than 
12 such as; polysorbate 85 (Tween 85) or polyoxyethylene 25-
glyceryl trioleate (Tagat TO). Type III systems contain blends of 
glycerides (oils), hydrophilic surfactants with HLB>12 such as; 
Cremophor RH40 [10, 11], Cremophor EL [12, 13], Tween 80 [14, 
15], Tween 20 [14] or Tagat O2 [16] and/or hydrophilic co-solvents 
such as, ethanol, propylene glycol or polyethylene glycol. Type III 
formulations which include water-soluble components are referred 
to as self-micro-emulsifying systems (SMEDDS) as they can lead to 
the production of a microemulsion on dispersion in GI tract (particle 
size ≈ 50 nm). Type III formulations can be subdivided into type IIIA 
and type IIIB according to the degree of hydrophilicity of these 
formulations. Type IIIA formulation contains approximately 50-60% 
triglycerides or mixed glyceride content, whereas type IIIB has less 
than 20%. Type IV formulations do not contain natural lipids and 
represent the most hydrophilic formulations. The HIV protease 
inhibitor amprenavir (Agenerase®) which contains TPGS as a 
surfactant and PEG 400 and propylene glycol as co-solvents [17] is an 
example of Type IV formulations which do not contain natural lipids 
and thus represent the most hydrophilic formulations. The 
optimization of cyclosporin as Neoral® is the archetypal example of 
Type IIIB according to the classification system proposed by Pouton [8, 
9]. The Neoral®
In this study blends of Miglyol 812, Imwitor 988 and various 
hydrophilic nonionic surfactants were optimized to produce 
microemulsion systems. The effect of varying weight ratio of each 
component on the emulsification performance for various 
microemulsion systems as determined by size measurement was 
investigated. Furthermore, the equilibrium phase behaviour study 
was also conducted to establish the mechanism by which 
hydrophilic surfactants influence emulsification process. 
 formulation uses approximately 20% co-solvent, 30% 
oil and 40 % hydrophilic nonionic surfactant (Cremophor RH40) and 
10% drug. Apparently, the use of Cremophor RH40 (polyoxyethylene-
(40)-hydrogenated caster oil) has significantly contributed to the 
success of this formulation as a microemulsion delivery system. Yet 
the role of this surfactant in the emulsification process from 
mechanistic and phase behaviour perspective has not been reported.  
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MATERIALS AND METHODS 
Materials 
Miglyol 812 (medium chain triglyceride) and Imwitor 988 (C8/C10 
mono/diglycerides) were supplied by Condea Chemie GmbH. Tagat 
TO (PEG-(25)-glyceryl trioleate) and Tagat O2
Methods 
 (polyoxyethylene-
(20)-glyceryl monooleate), supplied by Goldschmidt AG, Germany. 
Crillet 4 (Polyoxyethylene-(20)-sorbitan monooleate), also known as 
tween 80 or polysorbate 80 and crillet 1 (Polyoxyethylene-(20)-
sorbitan monolaurate), also known as Tween 20 or polysorbate 20 
were supplied as gifts from Croda UK. Cremophor RH 40 
(polyoxyethylene-(40)-hydrogenated caster oil) and cremophor EL 
(polyoxyethylene-(35)-caster oil) were obtained from BASF 
Corporation. All water used was Mili Q water.  
Miscibility ternary phase diagrams 
Regions of mutual solubility of various lipid formulations with a wide 
range of surfactants that represent different HLB values were 
determined using ternary phase diagrams. Miscibility diagrams of 
miglyol 812, imwitor 988 and various surfactants; tagat TO, tagat O2, 
crillet 4, crillet 1, cremophor RH 40 and cremophor EL were 
constructed. Each of the axes on the diagram represents the 
percentage contributes to the formulation by each of the three 
components (miglyol 812, imwitor 988 and a surfactant). 
Formulations of five grams which represent various percentages of 
Miglyol 812, Imwitor 988 and a surfactant on the ternary phase 
diagrams, were weighed in 20 g screw-capped vials (tops were rapped 
with cling film before caps were screwed on). Mixtures were placed in 
a water bath at 50 °C for 2 min before the three components were 
thoroughly vortexed. Mixtures were then kept for 24-48 h in an oven 
set up at 25°C before visual assessment. In the case of Miglyol 
812/Imwitor 988-Cremophor RH40 system, mixtures were kept for 
24-48 h in an oven set up at various storage temperatures of 15 °C, 25 
°C or 45 °C. Mixtures which formed a continuous single-phase were 
classified as miscible formulations. Samples that displayed two or 
more phases were described as immiscible systems. 
Self-emulsification 
Mixtures of oil and surfactant were produced by accurately weighing 
ingredients into screw-capped glass vials with tight closures followed 
by votrexing. Different proportions (w/w) of Miglyol 812/Imwitor 988 
(10:0, 9:1, 8:2, 7:3, 6:4, 5:5, 3:7, 1:9 and 0:10) containing between 5 
and 60% w/w surfactant were weighed first in the glass vials, tops 
were then rapped with cling film before caps were screwed on. The 
glass vials were held at 50 °C in a thermostated water bath held for 2 
minute before lipid mixtures were thoroughly vortexed. Lipid 
formulations were then left to equilibrate overnight in an oven set up 
at 25°C. Emulsions were prepared under conditions of gentle agitation 
at a controlled temperature of 37°C. Self-emulsifiable mixtures (1 gm) 
were introduced into 100 ml of Mili Q water in a 500-ml glass beaker 
held at 37°C in a thermostated water bath. All materials were pre-
equilibrated to the appropriate temperature. Emulsification under 
agitation conditions considered to be a reasonable simulation of the in 
vivo situation was carried out. Agitation was provided by gentle 
shaking on a mechanical shaker at 100 oscillations per min for 15 min. 
Systems which appeared to emulsify efficiently were studied further 
by particle size analysis. 
Analysis of mean emulsion droplet diameter (MEDD) 
For emulsions with droplet distributions above 1µm, low angle laser 
light diffraction (Malvern Mastersizer X) with small volume cell 
using 45 mm lens was used. On the other hand, Quasi-elastic light 
scattering (QELS, Malvern model LO-C photon correlation 
spectrometer) was used to analyze samples of submicron 
dispersions. For both techniques, experiments were performed in 
triplicate. Size distributions of the resultant emulsions were 
obtained and expressed as mean values of all data ± standard error. 
Equilbrium phase studies 
Phase behaviour studies were conducted by static composition 
method described by Hasan et al. [4]: Mixtures representing whole 
ternary phase diagram at 5%w/w intervals containing blends of oil, 
surfactant and water of total weight of 5 gm were weighed up in 
screw-capped glass vials. In order to make phase boundaries, 
additional compositions were made at 2.5%w/w intervals whenever is 
required. Oil compositions were heated to 70 °C in a thermostatically 
controlled water bath for 15 min and vortexed until homogeneity was 
achieved. Oil blends were then allowed to equilibrate at 25 °C for 24 h 
for phase identification using Alan crossed polarized viewer.  
RESULTS AND DISCUSSION 
Miscibility of ternary oil systems 
Fig. 1 (a, b, and c) depicts ternary phase diagrams displaying the 
miscibility of Miglyol 812/Imwitor 988-cremophor RH40 system at 
various storage temperatures 15 °C, 25 °C and 45 °C, respectively. As 
fig. 1 shows Miglyol 812 and Imwitor 988 are completely miscible at 
all temperatures used. Furthermore, it is evident that Cremophor 
RH40 in this system at temperatures 15 °C or 25 °C (fig. 1 a,b) is 
partially miscible in Imwitor 988 or Miglyol 812. Yet, it is important 
to note that blends of Cremophor RH40 and Imwitor 988 might be 
completely miscible and what we see from the area of immiscibility 
close to the Imwitor 988 line is due to the solidification of 
Cremophor RH40 at temperatures below its melting point (mp) 40 
°C. This is substantiated, however, as the area of immiscibility 
between Cremophor RH40 and Imwitor 988 has disappeared when 
oil blends were heated at 45 °C (fig. 1c) which is above the melting 
point of Cremophor RH40 or, when waxy Cremophor RH40 is 
replaced with its liquid unsaturated form Cremophor EL, see fig. 2. 
At 45 °C, however, only blends of cremophor RH40 and miglyol 812 
show partial miscibility as they form one bimodal curve. Generally, 
increasing the temperature leads to a reduction in the areas of 
immiscibility and thus miscibility is promoted. The line A-B depicted 
in fig. 1(a, b and c) represents the dilution of Miglyol 812/Imwitor 
988 ratio of 5:5 with increasing concentration of Cremophor RH40. 
It shows that the maximum amount of Cremophor RH40 that can be 
used to formulate isotropic blends is 20%, 40% or up to 90% at 
temperatures 15 °C, 25 °C and 45 °C, respectively. This suggests that 
reduction of the temperature expands the area of immiscibility and 
prompts crystallization of Cremophor RH40 which could result in 
drug precipitation. This nullifies the purpose of lipid formulations 
which are designed to improve the dissolution rate of poorly water-
soluble drugs and thus enhance absorption. Therefore, as it has been 
shown, the choice of Cremophor RH40 limits the range of acceptable 
oil formulations that can be used to produce microemulsion systems. 
The use of co-solvent in these systems might improve the range of 
reliable oil systems. Yet this, however, raises the issue of losing the 
solvent capacity of these formulations on dilution of the co-solvent 
in the lumen of the gut which might ensue in crystallization of the 
drug. Alternatively, to screen for other surfactants that could replace 
Cremophor RH40 in an attempt to expand area of miscibility and 
hence avoids precipitation of formulation due to variations in the 
ambient temperature; in particular the liquid surfactants such as, 
Cremophor EL, polysorbate 80/20 or Tagat O2.  
Fig. 2 shows the phase equilibrium in a three-component system of 
Miglyol 812/Imwitor 988 and Cremophor EL (polyoxyethylene-(35)-
caster oil). In contrast to the oil systems containing Cremophor RH 
40 (fig. 1), the ternary phase diagram depicted in fig. 2 displays a 
huge area of miscibility in which, Cremophor EL and Miglyol 812 
show partial miscibility as there is only one bimodal curve. The 
phase diagram depicted in fig. 2 reveals similar areas of phase 
equilibrium as the ternary oil mixtures which contain Cremophor 
RH 40 at 45 °C (fig. 1c). This suggests that the waxy nature of the 
surfactant is what causes the crystallization of these systems 
containing Cremophor RH40 and thus restricting the range of oil 
systems which can be fabricated. Cremophor RH40 is a waxy 
material at room temperature as it has a high melting point of ≈ 40 
°C and thus it restricts the range of oil mixtures which can be used in 
the blend. It also implicates the scale-up production of lipid 
formulations as special considerations are needed to handle and 
process a molten formulation on automated equipment. 
Solidification of the lipid system and thus drug precipitation can also 
occur during processing and storage due to variations in the 
environmental temperature. Therefore, in order to circumvent the 
crystallization of monoglycerides and/or highly ethoxylated 
Hasan  
Int J App Pharm, Vol 11, Issue 3, 2019, 98-108 
 
100 
surfactant molecules as in the case of Cremophor RH40, Cremophor 
EL can be a good alternative. Especially, if we know that Cremophor 
EL which is obtained by reacting ethylene oxide with caster oil in a 
molar ratio of 35 moles to 1 mole, is the liquid form of Cremophor 
RH40 (polyoxyethylene-(40)-hydrogenated caster oil) with slightly 
lower HLB values (HLB, between 12 and 14) as it contains less 
ethoxy residues per molecule. Therefore, comparable mean 
emulsion droplet diameter (MEDD) profiles would be anticipated 
from emulsification of oil systems containing either Cremophor RH 




Fig. 1: The phase equilibrium in a three-component system for miglyol 812/Imwitor 988-Cremophor RH40 formulation under various 
isothermal conditions: (a) 15 °C (b) 25 °C (c) 45 °C 
 
 
Fig. 2: Ternary phase diagram for Miglyol 812/Imwitor 988-Cremophor EL system displaying miscibility for formulations of various 
compositions 
 
Emulsification performance of oil systems 
In vitro particle size distribution analysis is one of the most 
important means to evaluate the stability of emulsions and also its in 
vivo fate after oral administration of the pre-concentrate, that is, a 
drug-surfactant-oil mix. Fig. 3 and 4 display the effect of surfactant 
concentration and oil: cosurfactant ratios of Miglyol 812/Imwitor 
988 on the emulsification performance of Miglyol 812/Imwitor 988-
Cremophor RH40 lipid system as determined by the mean emulsion 
droplet diameter (MEDD). Oil systems containing Miglyol 812, 
Imwitor 988 (co-surfactant) Imwitor 988 Imwitor 988
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Miglyol 812/Imwitior (9:1) or (8:2) blended with Cremophor RH40 
at room temperature show either complete immiscibility or 
isotropic single phase oil mixtures with very limited concentration 
of Cremophor RH40<10% w/w (fig. 1b, lines A-F, A-E and A-D). 
Hence, these oil mixtures were excluded from the emulsification 
study. On the other hand, for oil blends of Miglyol 812/Imwitor 
(7:3), Cremophor RH40 was included at a concentration below 25% 
w/w lest using more surfactant in the system will ensue in phase 
separation due to crystallization, see fig. 1b (line A-C). Generally, as 
depicted in fig. 3, the mean emulsion droplet diameter for Miglyol 
812/Imwitor 988-Cremopho RH40 system decreased with 
increasing surfactant concentration at all Miglyol 812/Imwitor 988 
ratios. Such a decrease in droplet size may be due to the availability 
of more surfactant to stabilize the oil-water interface. Furthermore, 
the decrease in the droplet size behavior reflects the formation of a 
better close-packed film of the surfactant at an oil-water interface 
which stabilizes the oil droplets [18]. Yet, the emulsification of 
Miglyol 812/Imwitor 988 blends of 7:3 ratio at surfactant content up 
to 20% w/w, which is the maximum concentration to avoid 
crystallization, did not affect the droplet size significantly and thus 
produced dispersions with high MEDD values. However, with 
increasing the cosurfactant content (Imwitor 988) in the Miglyol 
812/Imwitor 988-Cremophor RH40 system, the droplet size 
decreased substantially. This effect, however, is up to a point beyond 
which further increment of the co-surfactant would increase the 
MEDD values and thus more surfactant is needed to obtain 
equivalent MEDD values. Optimum dispersions of near optical clarity 
which were classified as self-micro-emulsifying systems were 
obtained at Miglyol 812/Imwitor 988 ratios of 6:4 or 5:5 (1:1) at 
Cremophor RH40 concentrations ≥ 15% w/w with minimum MEDD 
values of around 30 nm at a surfactant concentration of 30% w/w. 
Nonetheless, any further increase in the cosurfactant content as 
when the system had 7 parts of Imwitor 988 (Miglyol 812/Imwitor 
988) (3:7) MEDD value significantly increased and at least more 
20% w/w of Cremophor RH40 is required to obtain clear 
dispersions. This indicates that regardless of Miglyol/Imwitor 988 
ratio in the oil blends, microemulsions can still be obtained provided 
higher surfactant concentration is used. Yet, this raises a serious 
problem of damage to the gastrointestinal mucosa, as these systems 
contain a relatively large amount of surfactants. Nonetheless, 
contour plot for the emulsification performance of Miglyol 
812/Imwitor 988-Cremophor RH40 system (fig. 4) shows an 
optimum blend of Miglyol 812/Imwitor 988 at 1:1 ratio which has 
produced the finest dispersions. A decrease in MEDD was observed 
with an increase in cosurfactant concentration from 30% to 50%, 
after which the MEDD was slightly increased. Similar observations 
have been reported [19-20] where a further increase in cosurfactant 
concentration increased the droplet size. This was demonstrated by 
Gao et al. [20] using microemulsion systems containing Captex-355 
as an oil, Cremophor EL as a surfactant, Transcutol as a cosurfactant 
and saline. This is also confirmed in a recent study by Hasan et al. [4] 
using formulation consisting of {Miglyol 812/Imwitor 988} and 
Tagat TO. Optimized self-microemulsifying system with aqueous 
dispersions of relatively lower MEDDS values of ≈ 50 nm was 
obtained on including 30%w/w Imwitor 988 in the oil blend. 
Further incorporation of more Imwitor 988 in the oil mix ensued in 
increases in MEDD values hence, optimum robust self-micro 
emulsifying lipid system of Miglyol 812/Imwitor 988-Tagat TO was 
fabricate at ratios of 70(70/30)30). It is important to note here that 
the need for a cosurfactant is related to the fact that each head group 
unit is hydrophilic. Therefore, the addition of an extra unit 
considerably increases the hydrophilicity of the surfactant and 
hence, it is made harder to achieve the correct balance of the 
hydrophobic and hydrophilic portions of the surfactant required for 
the production of a microemulsion. Instead, this balance has to be 
achieved by the use of a cosurfactant [21]. The addition of surfactant 
to the microemulsion systems causes the interfacial film to condense 
and to be stable, while the addition of cosurfactant causes the film to 
expand [22]. When a cosurfactant is added to the system with the 
surfactant, it lowers the interfacial tension, fluidizes the 
hydrocarbon region of the interfacial film and decreases the bending 
stress of the interface [23]. As Imwitor 988 is polar oil due to the 
glycerol mono-caprylate content (≈ 50%), the polarity of oil droplets 
is optimized at a certain ratio of Miglyol 812/Imwitor 988 after 
which, any further increase in the Imwitor 988 content would affect 
the hydrophilic-lipophilic balance (HLB) of the system and 
consequently the emulsification is affected. The role of Imwitor 988 
as a co-surfactant in stabilizing O/W interface and hence reducing 
MEDD values of aqueous dispersions is illustrated in fig. 5. It is 
suggested by Hasan et al. [4] that Imwitor 988 can penetrate into the 
void spaces among surfactant molecules in the surfactant film 
around the oil droplet which can result in increasing interfacial 
fluidity, lowering the interfacial tension and thus stabilizing O/W 
interface. When saturation around oil droplets at the O/W interface 
is achieved at optimum concentrations of co-surfactant in the oil 
mixture, decrease in MEDD profiles is observed. Yet, on further 
including more Imwitor 988 which has limited solubility in water at 
this point particle size of the resultant dispersion is increased as the 
excess of Imwitor 988 which has no place to occupy in the surfactant 
film around droplets of oil disperses in the aqueous phase. 
 
 
Fig. 3: Mean emulsion droplet diameter (MEDD) profiles for self-emulsified systems containing different ratios of Miglyol 812/Imwitor 
988 and increasing concentration of cremophor RH40. Bars represent standard errors (n = 3) 
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Fig. 4: Contour plot representations of MEDD data for the emulsification of Miglyol 812/Imwitor 988-Cremophor RH40 system as a 
function of surfactant concentration and the ratio of Imwitor 988/Miglyol 812 in the oil blend 
 
 
Fig. 5: Effect of the co-surfactant and surfactant in stabilizing the O/W interface 
 
However, in a study by Kawakami et al. [24, 25], they concluded that 
surface tension and polarity measurements of oil blends did not 
correlate with the system ability to form microemulsions as 
determined by the amount of oil solubilized in the surfactant-water 
mixtures. They demonstrated that the most effective mixing ratio to 
mimic the solubilization behaviour was 1:1 of glycerol monocaprylic 
ester (MCG) and propyleneglycol dicaprylic ester (DCPG), although 
the later was hardly solubilized in any surfactant solutions. Yet, they 
offered one possible assumption whereby the DCPG phase may be 
enclosed in a shell of the MCG rich phase hence MCG molecules may 
penetrate into the surfactant layer as the penetration of polar oils 
into surfactant layer has been observed [26, 27]. This will be 
reflected upon when we study the mechanistic processes involved in 
the emulsification of Miglyol 812/Imwitor 988-Cremophor RH40 
system. On the other hand, in this investigation the emulsification of 
Imwitor 988 (Glycerol mono-/di-caprylate {1:1})-Cremophor RH40 
system (i.e. without any Miglyol 812) produced dispersions with 
inconsistent and high MEDD values which suggest the need to 
include medium chain triglyceride (MCT) in the formulation. 
Apparently, this contrasts results from Kawakami et al.[24] in the 
case of Cremophor RH40 whereby maximum solubilization occurred 
at MCG/DCPG ratio of 1:1. This could be attributed to the fact that in 
their study the solubilization behaviour of ternary oil mix MCG, 
DCPG and MCT was not optimized as they investigated these ester 
oils each one alone or as a binary mix. Also, they have used one 
surfactant concentration that is, 10% w/w which appears to be very 
small when considering forming o/w microemulsions. 
In an attempt to prevaricate the crystallization tendency of 
Cremophor RH40 in the pre-microemulsion concentrate and thus 
expands the range of mixtures which can be used, alternative 
surfactants were investigated such as, Cremophor EL, Crillet 4, 
Crillet 1 and Tagat O2. The emulsification profiles with contour plot 
for Miglyol 812/Imwitor 988-Cremophor EL are depicted in fig. 6 
and 7. Cremophor EL (polyoxyethylene-(35)-caster oil) is 
considered to be the liquid form of Cremophor RH40 (HLB, 14-16) 
yet with lower HLB value (12-14) due to less ethoxylation number. 
This has reflected on the area of miscibility as depicted by the 
ternary phase diagram (fig. 2) which offers wide range of potential 
pre-microemulsion mixtures without restriction on the amount of 
surfactant to be included. As illustrated in fig. 6, the emulsification 
profiles of Miglyol 812/Imwitor 988-Cremophor EL have shown 
trends similar to formulations containing Cremophor RH40 whereby 
droplet size is controlled by the surfactant concentration and the oil-
cosurfactant ratio. With increasing the amount of surfactant or 
cosurfactant in the system, smaller MEDD could be obtained. Yet, the 
increase in the cosurfactant-oil ratio is up to a point beyond which 
the polarity of oil droplets is enhanced and thus the HLB of the oil 
system becomes out of the range to produce microemulsions and 
consequently, the MEDD is increased. As depicted in fig. 6, the 
emulsification performance of Miglyol 812/Imwitor 988 (7:3) using 
Cremophor EL has produced dispersions with high MEDD values. 
Equivalent MEDD profiles were obtained at 812/Imwitor 988 (6:4), 
(5:5) or (3:7) using Cremophor EL at a concentration of ≥15% w/w. 
This is in contrast to the variations in the emulsification profiles of 
Miglyol 812/Imwitor 988 (6:4), (5:5) or (3:7) using Cremophor 
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RH40 (fig. 3). Nonetheless, it is evident from contour 
representations of the MEDD data depicted in fig. 7 that optimum 
MEDD profiles are obtained at co-surfactant (Imwitor 988) 
concentration extended from 40-70 %w/w in the oil blend as flat 
contour lines are observed at those co-surfactant ratios. Unlike the 
minimum trough observed at Imwitor 988 concentration of 50% 
w/w in the contour representation of the MEDD for Miglyol 
812/Imwitor 988-Cremophor RH40 system (fig. 3). Minimum MEDD 
of 30 nm at approximately 35% w/w Cremophor EL has extended 
over Imwitor 988 weight percentage from 50-70%. This broad range 
of cosurfactant amount in the oil blend which has produced 
microemulsion systems with no variations in the emulsification 
profiles is attributable to the relatively low HLB value of Cremophor 
EL comparing to RH 40. As discussed earlier, the use of cosurfactant 
normally adds to the total polarity of oil droplets and hence 
increases the HLB of the system. If the surfactant has already high 
HLB value as in the case of Cremophor RH40 (HLB between 14 
and16), the amount of cosurfactant that is needed to obtain an HLB 
value of the oil mix within the range for producing microemulsion 
systems is limited. However, for Cremophor EL which has 
relatively lower HLB value (between 12 and 14), the range of 
cosurfactant that is required to produce an oil mix with an HLB 
value which is within the range to obtain fine dispersions is 
widened. Last but not least, provided optimum oil blends are used, 
Cremophor EL offers a good alternative to Cremophor RH40 for 
the formulation of SMEDDS, see table 1. In a study by Gao et al. 
[20] using Captex 355® as an oil, Cremophor EL® as a surfactant, 
Transcutol® as a cosurfactant and saline, microemulsion systems 
were optimized at Cremophor EL®:Transcutol®:Captex 355®
  
, 
10:5:4 i.e. oil-cosurfactant ratio of approximately 1:1 with 50% 
surfactant. Though the oil-cosurfactant ratio of the oil blend agrees 
with our findings yet the use of high content of the surfactant in 
his system raises serious toxicity issues. Similar optimal ratio oil-
cosurfactant ratio (1:1) was also in the formulation of SMEDDS 
composed of Labrafac: oleic acid: Cremophor EL: Transcutol P=40: 
10: 40: 10 (w/w) [28]. 
 
Fig. 6: Emulsification profiles of self-emulsified systems containing different ratios of Miglyol 812/Imwitor 988 and increasing 
concentration of Cremophor EL. Lipid formulations were emulsified in water at 37 °C for 15 min. MEDD values were measured by photon 
correlation spectrometer (PCS). Bars Represent Standard Errors (n = 3) 
 
 
Fig. 7: Three-dimensional graph and contour plot representations of MEDD data for the emulsification of Miglyol 812/Imwitor 988-
Cremophor EL system as a function of surfactant concentration and the ratio of Imwitor 988/Miglyol 812 in the oil blend 
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Fig. 8: Three-dimensional graph and contour plot representations of MEDD data for the emulsification of Miglyol 812/Imwitor 988-Crillet 
4 system as a function of surfactant concentration and ratio of Imwitor 988/Miglyol 812 in the oil blend 
 
Table 1: Comparison of emulsification performance for microemulsion systems prepared using various hydrophilic surfactants at various 











 MEDD (nm)   
10 110.40±3.70 133.80±2.30 Off range Off range 
15 65.25±0.21 83.00±0.42 Off range Off range 
20 45.55±0.78 54.00±1.60 220.33±4.65 Off range 
25 36.50±2.40 41.50±0.57 75.10±0.40 Off range 
30 28.95±1.20 35.90±0.99 38.80±1.00 153.00±6.02 
35 27.2±0.00 27.20±0.00 32.80±0.20 46.20±0.60 
40 Unstable 25.00±2.50 28.00±1.30 35.70±0.40 
 
Table 2: Effect of surfactant hydrophilicity on the optimum weight ratio of oil in the oil-surfactant blend for various microemulsion 
systems, surfactants with HLB values<12 are considered to be lipophilic [29] 
Surfactant type HLB of surfactant Wt % of Miglyol in (Miglyol/Imwitor) 
Tagat TO 11 70% 
Cremophor EL 12-14 30-60% 
Cremophor RH40 14-16 30-60% 
Crillet 4 15 40% 
Tagat O2 15 40% 
 
Moreover, in an attempt to screen for more self-micro-emulsifying 
systems using blends of Miglyol 812/Imwitor 988 new hydrophilic 
surfactants were investigated in this study including; Crillet 4 
(polyoxyethylene(20) sorbitan monooleate), Crillet 1 
(Polyoxyethylene-(20)-sorbitan monolaurate) and Tagat O2 
(polyoxyethylene-(20)-glyceryl monooleate. Optimal self-micro-
emulsifying systems were obtained at Miglyol 812/Imwitor 988 
ratio of 4:6 in the case of using Crillet 4 and Tagat O2. Yet, Crillet 1 
has shown no potential for pre-microemulsion formulations hence it 
has produced dispersions with high MEDD values at all Miglyol 
812/Imwitor ratios (data not shown). The emulsification of Miglyol 
812/Imwitor 988 (7:3), (3:7) and (1:9)-Crillet 4 have produced self-
emulsified drug delivery systems (SEDDS) with MEDD values 
between 1 and 5 µm (data not shown). Similar to oil systems 
containing either Cremophor RH40 or EL (fig. 3 and 6, respectively); 
increasing the surfactant concentration or the cosurfactant to oil 
ratio in the Miglyol 812/Imwitor 988-Crillet 4 system reduces the 
MEDD values. Yet, the increase of the co-surfactant in the oil blend is 
also to a point beyond which further increment would ensue in an 
increase in the MEDD values. As the the contour plot for Miglyol 
812/Imwitor 988-Crillet 4 system depicted in fig. 8, microemulsion 
systems are optimised at Miglyol 812/Imwitor 988 ratio of 4:6. The 
contour plot representation of the MEDD data for this system shows 
a minimum trough of 30 nm at a cosurfactant-oil ratio of 60:40 and 
using approximately 35% w/w Crillet 4 i.e. 65(60/40)35, see table 1. 
This ratio of oil blend was also found to be the optimum in a study 
by Kawakami et al. [24]. They found that the combination of MCG 
with MCT at the ratio of 6:4 in the case of Tween 80 (equivalent to 
Crillet 4) was effective to achieve maximum oil solubilization. It is 
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has been able to produce SMEDDS with a wider range of Miglyol 
812/Imwitor blends than in the case of Crillet 4 (polysorbate 80). 
Hence Cremophor RH40 and EL are caster oil derivatives, these 
results suggest that the type and structure of the lipophilic moiety is 
of paramount importance to the self-emulsification process. 
Furthermore, the freedom of chain movement and orientation 
imparted by the removal of the sorbitan ring should aid in the ease 
of molecular interactions [30].  
In contrast to oil mixtures containing Crillet 4, Miglyol 812/Imwitor 
988-Crillet 1 has shown no potential for pre-microemulsion 
formulations hence it has produced dispersions with high MEDD 
values at all Miglyol 812/Imwitor ratios (data not shown). This was 
also observed by Kawakami et al. [24] whereby Tween 80 
(equivalent to Crillet 4) was able to solubilise 23% w/w of oil 
mixture composed of 1:1 DCPG and MCG vis-à-vis 1% in the case of 
Tween 20 (equivalent to Crillet 1). This might be due to the fact that 
Crillet 1 (Polyoxyethylene-(20)-sorbitan monolaurate) has relatively 
higher HLB value (16.7) than Crillet 4 (polyoxyethylene-(20)-
sorbitan monooleate, HLB 15.0). This indicates that in order to 
obtain an equivalent optimum HLBmix
The emulsification profiles of Miglyol 812/Imwitor 988 at ratios of 
(6:4) or (5:5) using Tagat O2 (polyoxyethylene-(20)-glyceryl 
monooleate, HLB =15) produced MEDD profiles comparable to the 
emulsification of same oil mixtures but containing Crillet 4 (data not 
shown). Furthermore, similar to blends containing Crillet 4, optimal 
microemulsion systems were obtained for Tagat O2 using blends of 
Miglyol 812/Imwitor 988 at 4:6. Yet, as table 1 suggests, at 
surfactant concentration<30% w/w, oil mixtures containing Crillet 4 
appear to be more emulsifiable than Tagat O2. Yet, both surfactants 
at a concentration ≥35% w/w produced fine dispersions with almost 
equivalent MEDD values. These results have demonstrated that the 
emulsification performance of oil systems containing either Tagat O2 
or Crillet 4 have shown a comparable trend with slight variations. This 
could be attributed to the fact that both surfactants have same HLB 
value (15) and more importantly similar chemical structure, yet with 
the lack of sorbitan ring in the case of Tagat O2. This suggests that the 
sorbitan nucleus structure in the case of polyoxyethylene monoalkyl 
esters is not the major factor to determine good self-emulsification 
with triglyceride oils. Similar observations were made by Wakerly 
[30], whereby Crillet 11 (polyoxyethylene-(4)-sorbitan mono-laurate) 
gave a performance similar to alcohol ethoxylates of equivalent HLB. 
Further evidence was also demonstrated from studies with Atlox 
1045A, an ethoxylated sorbital (opened sorbitan ring) ester of mainly 
oleic acid (HLB 13.2) [30]. This surfactant exhibited good self-
emulsification with Miglyol 812 and had an equivalent HLB value to 
Crillet 11. These results have shown that Cremophor RH40 is a good 
surfactant for a formulation of SMEDDS yet is not a special case. It is 
possible to obtain very fine dispersions with other non-ionic 
surfactants such as, Cremophor EL, polysorbate 80 or Tagat O2, 
provided right oil-cosurfactant ratio is used to optimise the 
performance of SMEDDS, see table 1. Nonetheless, as table 1 suggests 
at surfactant concentrations ≤ 15% w/w Cremophor RH40 or 
Cremophor EL has shown relatively better emulsification performance 
and thus maximum oil solubilization than Tagat O2 or Crillet 4.  
 of Miglyol 812/Imwitor 988-
Crillet 4 system for producing microemulsion systems, Crillet 1 
needs to be mixed with oil blends high in Miglyol 812 content of at 
least ≥ 70%. Yet, according to the ternary equilibrium phase diagram 
for Miglyol 812/Imwitor 988-Crillet 1, these systems do not form 
stable isotropic one phase concentrates. Furthermore, it was 
surmised that the presence of oleic acid residues as the major 
constituent of the hydrophobic portion of the surfactant molecule 
were essential for mixtures with Miglyol 812 to exhibit good 
emulsification [30]. 
Mechanistics of the emulsification process 
General considerations of the putative mechanisms which have been 
proposed to explain spontaneous and self-emulsification processes 
have been discussed thoroughly in many reports [3-4, 30-33]. In 
practice, disruption of the oil-water interface is caused by 
penetration of water into the formulation through the network of 
aqueous channels or diffusion of hydrophilic components such as, 
cosolvents and hydrophilic surfactants away from the formulation 
into the aqueous phase see fig. 9. Both of these phenomena can be 
studied using equilibrium phase diagrams, which alongside with 
droplet size analysis can allow the optimisation performance of self-
emulsified systems. The precise mechanisms of emulsification 
remain the subject of speculation. Nonetheless, studies by Wakerly 
[30] and Pouton [31] using either Tagat TO or Tween 85 with 
Miglyol 812 have identified an empirical link between self-
emulsification, liquid crystal formation, phase inversion 
temperature and enhanced water solubilization by oily systems. 
Nevertheless, recent studies by Hasan et al. [4] have demonstrated 
that the inclusion of medium C8/C10 mono/diglycerides (Imwitor 
988) in Miglyol 812-Tagat TO system has transformed dynamic 
equilibrium phase map of the oil system on interaction with water. 
Thus, the enhancement of water solubilization (L2 phase) was of 
paramount importance to the mechanistics of emulsification for type 
II lipid class systems. Furthermore, the enhanced water 
solubilization is linked to ease of emulsification and low droplet size 
[34]. This also appears to be true for type III systems investigated 
here which contain hydrophilic materials (surfactants with HLB>12 
and/or water-soluble cosolvents). For these systems, where a 
hydrophilic surfactant or cosolvent is present, rapid emulsification 
occurs by a mechanism which could be delineated as ‘diffusion and 
stranding’ (fig. 9b). Diffusion of water into the oil phase converts it 
to w/o microemulsion (L2
In order to give insight into the mechanistic process of 
emulsification in type III systems, ternary equilibrium phase 
diagrams on dilution with water were constructed. Furthermore, 
emulsification profiles as determined by droplet size measurement 
were also analyzed in the view of equilibrium phase behaviour 
study. Miglyol 812/Imwitor 988-Cremophor RH40 system was 
selected for this phase study as an archetypal example of type III 
formulations which forms fine dispersions. The triangular 
equilibrium phase behaviour diagram for Miglyol 812/Imwitor 
(5:5)-Cremophor RH40 system on dilution with water is depicted in 
fig. 10. The oil blend of Miglyol 812/Imwitor 988 at ratio of 5:5 was 
first investigated here as it was found to be the optimum for self-
micro-emulsification in the case of Cremophor RH40. As fig. 10 
displays, Miglyol 812/Imwitor 988 (5:5) blend is virtually 
immiscible with water as it forms two phase system (L
 phase) then there will be a significant 
migration of material which partitions and becomes diluted into the 
bulk aqueous phase [35]. This hydrophilic material dissolves the 
water-insoluble component into the aqueous phase as a solubilized 
system forming a bicontinuous microemulsion. On further diffusion, 
the concentration of the hydrophilic component becomes too dilute 
to fully solubilise the oil and consequently the water-insoluble oil 
separates as a second phase-forming an oil droplet. In order to obtain 
uniformly small oil droplets in water, the pre-concentrate oil mixture 
has to be either slightly lipophilic or hydrophilic depending on the 
hydrophilic-lipophilic balance (HLB) of the surfactant. Therefore, for 
systems containing lipophilic surfactants such as Tagat TO (HLB 11) 
the injected drop has to be slightly lipophilic; i.e., the oil to cosurfactant 
ratio has to be slightly greater than that of the excess oil phase in 
equilibrium with bicontinuous microemulsion [33]. Weight ratio of oil-
to-cosurfactant at 70/30 has been optimum for Tagat TO system, see 
table 2. On the other hand, in the case of hydrophilic surfactants (HLB 
≥12) such as; Cremophor RH40, EL, Crillet 4 or Tagat O2, oil blend 
(oil/cosurfactant) has to be slightly hydrophilic which means less 
weight ratio of oil (Miglyol 812) needs to be used, see table 2. Thus, for 
some optimal range of initial drop compositions, an emulsion of small 
oil droplets in water can be achieved. 
1+L2). On the 
other hand, Cremophor RH 40 as a hydrophilic surfactant with HLB 
value of 14-16 is soluble in water. Therefore, on aqueous dilution, 
increasing the oil content in the formulation results in expansion of 
the L1+L2 region and consequently, more surfactant is needed to 
homogenize the system into isotropic mixtures (L2 or L1). L1+L2 
region reached a maximum when the system contained 45-65% 
w/w oil and hence, minimum Cremophor RH40 concentration of 
25% w/w was required to obtain clear mixtures close to the water 
apex in the ternary phase diagram, see fig. 10. Interestingly, this 
system at Cremophor RH40 ratio fraction in the oil mixture of>20 
and on dilution with water between 20 and 50% w/w formed areas 
of various phases containing liquid crystalline material (LC, L2+LC 
and L1+L2+LC) which intercepted L1 and L2 regions (see footnote in 
Hasan  
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fig. 10 for phase description). Furthermore, an area of micellar 
solution (L1) was obtained on further dilution with water (>50% 
w/w). The ability of this system to solubilise the oil into micellar 
solution is attributable to the robust solubilizing capacity of 
Cremophor RH40 provided sufficient concentration is used. The LC 
phase and in particular the typical LCa is generally associated with 
self-emulsification. The LC phase is viscous and exhibits white 
birefringence. In contrast, the transparent liquid crystalline 
dispersion phase, denoted LCa, differs from the LC phase in that it 
displays low viscosity and multicolored birefringence. The nature of 
the LCa is thought to consist of a dispersion of lamellar liquid crystal 
in L2 phase [36-37]. There has been no attempt in this phase study 
to differentiate between various types of LC phases, as their role in 
the mechanistics of emulsification for this system appears to be not 
crucial. Yet, the formation of LC phases after maximum solubilization 
of water (L2) of approximately 20% occurred, might have facilitated 
further penetration of water through the aqueous channels which 
resulted in further diffusion of the Cremophor RH40 away to the 
aqueous phase and consequently, the system became solubilized 
into micellar solution (L1). The line (A-B) depicted in fig. 10 
represents the dilution of Miglyol 812/Imwitor 988 (5:5) blend and 
Cremophor RH40 mixtures at the ratio of 70/30 with water. The 
dilution of the initial oil mixture (L2) with water would pass through 
L2→L1+L2→L1+L2+LCa→L1 phases. Therefore, it is likely that the 
MEDD profile for the previous system (70(50/50)30) which is 
presented in fig. 3 is considered to be the dilution of the micellar 
solution (L1
 
 phase) with water to give a final composition with 
relatively low MEDD values. 
 
Fig. 9: Mechanistics of self-emulsification process; (a) Water-insoluble systems (eg. Type II SEDDS): penetration of water leads to the 
formation of liquid crystals at the oil-water interface which allow further penetration of water down aqueous channels, causing an 
increase in surface pressure and interfacial disruption which ensue in fine emulsion droplets to be exudated from the interface. (b) 
Systems containing a water-soluble component (Type III): ‘diffusion and stranding’ mechanism is attributed to the emulsification of these 
systems which can lead to very fine dispersions. As the solvent capacity is lost due to the diffusion of the hydrophilic component, oil and 
drug form a separate phase. Adapted from reference [4] 
 
 
Fig. 10: Triangular equilibrium phase diagram for the Miglyol 812/Imwitor 988 (5:5)-Cremophor RH40-water system at 25 °C. Lines A-B, 
A-C and A-D represent the dilution of Miglyol 812/Imwitor 988 (5:5) blend and Cremophor RH40 mixtures at ratios 70/30, 80/20 or 
90/10, respectively, with water. Aqueous-based liquids are designated L1, oil-based liquids (L2) and liquid crystal phases “white” 
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Fig. 11: Triangular equilibrium phase diagram for the Imwitor 988-Cremophor RH40-water system at 25 °C. Lines A-B and A-C represent 
the dilution of Imwitor 988/Cremophor RH40 binary mixtures at ratios 50/50 and 70/30, respectively, with water 
 
On the other hand, the emulsification of Miglyol 812/Imwitor 988 
(5:5)-Cremophor RH40 at ratios of (90(50/50)10) depicted in fig. 3 
considered to be the dilution of L1+L2 phase (fig. 10, line A-D). 
Therefore, it is anticipated for this system to produce high MEDD 
values. Nonetheless, increasing the surfactant ratio in the oil-
surfactant pre-concentrate would, on aqueous dilution, shift the 
L1+L2 phase towards the micellar solution region (L1
In order to investigate the importance of triglyceride source (Miglyol 
812) in the mechanisms of emulsification in type III systems, equilibrium 
phase behaviour for Imwitor 988-Crmophor RH40 system on dilution 
with water was studied and presented in fig. 11. The ternary equilibrium 
phase diagram for Imwitor 988-Cremophor RH40-water system shows 
huge extension in the L1+L2 region with the comparison to the same 
system but containing Miglyol 812/Imwitor 988 at 1:1 ratio (fig. 10). For 
Imwitor 988-Cremophor RH40-water system, an optimum oil-to-
surfactant ratio at 50/50 is required to transform two-phase mixtures 
into isotropic phases (L2 or L1) (line A-B, fig. 11) vis-à-vis 70/30 in the 
case of Miglyol 812/Imwitor (5:5)-Cremophor RH40 system (line A-B, 
fig. 10). On the other hand, the emulsification of Imwitor 988-Cremophor 
RH40 at ratio of 70/30 is considered to be the dilution of L1+L2 phase 
(line A-C, fig. 11) and hence it is anticipated for this system to produce 
relatively high MEDD values. This indicates that in order to obtain pre-
microemulsion concentrate in the case of Imwitor 988-Cremophor RH40 
system more surfactant needs to be used which might raise toxicity 
issues. Therefore, including Miglyol 812 in the oil blend is important to 
obtain microemulsion systems in the case of type III lipid formulations. 
However, Miglyol 812 is required at optimum ratios to produce a pre-
concentrate of oil-cosurfactant-surfactant with right HLB mix for self-
micro-emulsification. Furthermore, in contrast to the extended areas 
which contained LC material in the case of Miglyol 812/Imwitor (5:5)-
Cremophor RH40-water system, limited areas of LC phases were 
observed in the Imwitor 988-Cremophor RH40-water system (fig. 10 
and 11, respectively). This might be attributed to the solvent capacity of 
Imwitor 988 in dissolving LC material due to high monoglyceride 
content and moreover, its ability as polar oil to depress the phase 
inversion temperature (PIT) of the system.  
) close to the 
water apex in the triangular phase diagram (lines A-D, A-C, and A-B, 
fig. 10), and consequently, fine dispersions are obtained. This is in 
agreement with the droplet size measurements depicted in fig. 3, 
whereby MEDD is reduced by increasing the surfactant 
concentration in the oil system. Furthermore, as the line A-B 
depicted in fig. 10 shows, Miglyol 812/Imwitor 988 (5:5)-
Cremophor RH40 system at a ratio of 70/30 is thought to be the 
optimum for micro-emulsification in this system, which also agrees 
with the contour representation of the MEDD depicted in fig. 4.  
CONCLUSION 
There are various key elements in the oil composite that have to be 
optimized for successful lipid-based drug delivery systems. An oil-
cosurfactant ratio is one of these factors which affect the 
physicochemical characteristics of the resultant microemulsion 
systems designed for oral delivery. Oil blends of Miglyol 812 as an oil 
and Imwitor 988 as a cosurfactant were optimized for microemulsion 
systems at ratios of 1:1 in the case of Cremophor RH40 or EL, and at 
2:3 in the case of Crillet 4 or Tagat O2. Furthermore, Chemical 
structure of surfactants and their HLB values are amongst the 
important factors which affect microemulsion systems. For type III 
lipid systems to obtain small droplet size and fast dispersion rate, 
hydrophilic surfactants with HLB values between 13 and 15 were 
found to be the best. Furthermore, hydrophilic surfactants of caster oil 
derivative or with oleic acid residue were found to be the most 
effective for microemulsion systems. Spontaneous micro-
emulsification in type III lipid system was attributed to the “diffusion 
and stranding” theory whereby, diffusion of water into the oil mixture 
caused migration of the hydrophilic material away into the aqueous 
phase leading leading to nucleation oil droplets. Yet, the formation of 
liquid crystalline phases as intermediate phases during dilution of the 
oil formulation with water appears to be quintessential for the 
mechanistics of emulsification regardless type of lipid class system.  
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